Pilot study evaluating intravenous amoxicillin-clavulanate as an alternative to piperacillin-tazobactam for general surgery patients

In this point-prevalence survey followed by prospective audit and feedback at 4 tertiary-care hospitals in Calgary, Alberta, Canada, we evaluated whether intravenous amoxicillin-clavulanate may be used as a narrower-spectrum alternative to intravenous piperacillin-tazobactam for patients admitted to...

Descripción completa

Detalles Bibliográficos
Autores principales: Drost, Sarah A., Rajakumar, Irina, Rennert-May, Elissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Concise Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028943/
https://www.ncbi.nlm.nih.gov/pubmed/36960092
http://dx.doi.org/10.1017/ash.2023.133
_version_ 1784910048115294208
author Drost, Sarah A.
Rajakumar, Irina
Rennert-May, Elissa
author_facet Drost, Sarah A.
Rajakumar, Irina
Rennert-May, Elissa
author_sort Drost, Sarah A.
collection PubMed
description In this point-prevalence survey followed by prospective audit and feedback at 4 tertiary-care hospitals in Calgary, Alberta, Canada, we evaluated whether intravenous amoxicillin-clavulanate may be used as a narrower-spectrum alternative to intravenous piperacillin-tazobactam for patients admitted to general surgery services.
format Online
Article
Text
id pubmed-10028943
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-100289432023-03-22 Pilot study evaluating intravenous amoxicillin-clavulanate as an alternative to piperacillin-tazobactam for general surgery patients Drost, Sarah A. Rajakumar, Irina Rennert-May, Elissa Antimicrob Steward Healthc Epidemiol Concise Communication In this point-prevalence survey followed by prospective audit and feedback at 4 tertiary-care hospitals in Calgary, Alberta, Canada, we evaluated whether intravenous amoxicillin-clavulanate may be used as a narrower-spectrum alternative to intravenous piperacillin-tazobactam for patients admitted to general surgery services. Cambridge University Press 2023-03-03 /pmc/articles/PMC10028943/ /pubmed/36960092 http://dx.doi.org/10.1017/ash.2023.133 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
spellingShingle Concise Communication
Drost, Sarah A.
Rajakumar, Irina
Rennert-May, Elissa
Pilot study evaluating intravenous amoxicillin-clavulanate as an alternative to piperacillin-tazobactam for general surgery patients
title Pilot study evaluating intravenous amoxicillin-clavulanate as an alternative to piperacillin-tazobactam for general surgery patients
title_full Pilot study evaluating intravenous amoxicillin-clavulanate as an alternative to piperacillin-tazobactam for general surgery patients
title_fullStr Pilot study evaluating intravenous amoxicillin-clavulanate as an alternative to piperacillin-tazobactam for general surgery patients
title_full_unstemmed Pilot study evaluating intravenous amoxicillin-clavulanate as an alternative to piperacillin-tazobactam for general surgery patients
title_short Pilot study evaluating intravenous amoxicillin-clavulanate as an alternative to piperacillin-tazobactam for general surgery patients
title_sort pilot study evaluating intravenous amoxicillin-clavulanate as an alternative to piperacillin-tazobactam for general surgery patients
topic Concise Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028943/
https://www.ncbi.nlm.nih.gov/pubmed/36960092
http://dx.doi.org/10.1017/ash.2023.133
work_keys_str_mv AT drostsaraha pilotstudyevaluatingintravenousamoxicillinclavulanateasanalternativetopiperacillintazobactamforgeneralsurgerypatients
AT rajakumaririna pilotstudyevaluatingintravenousamoxicillinclavulanateasanalternativetopiperacillintazobactamforgeneralsurgerypatients
AT rennertmayelissa pilotstudyevaluatingintravenousamoxicillinclavulanateasanalternativetopiperacillintazobactamforgeneralsurgerypatients

Ejemplares similares